Head of Innovation
Rebecca is Head of Innovation at Apollo (Lloyd’s Syndicates 1969 and 1971) and an underwriter within Apollo ibott 1971 (Insuring the Businesses of Tomorrow Today), a dedicated Syndicate at Lloyd’s of London specialised in data driven underwriting with a focus on the sharing economy and new mobility. Rebecca lead the successful creation and underwriting of the landmark first bespoke autonomous vehicle insurance policy wording in the UK and Europe, with Apollo insuring the first fully autonomous on-road vehicle journey in 2022. Rebecca, through Apollo, works with Autonomous Vehicle technology clients spanning the globe to craft fit-for-purpose, tailored insurance solutions designed to specifically address the unique risks associated with Autonomous Vehicle technology. Holding an LLB in Law from University College London and the Legal Practice Course (LPC), Rebecca Marsden began her career in Fixed Income, Currency and Commodities trading with Goldman Sachs in 2005, before moving into a Leveraged Finance and Capital Markets. Rebecca joined the insurance market in 2011, where she spent four years in the financial solutions division of a global broker, advising investment banking clients seeking to utilise credit insurance as a risk mitigant, before moving into underwriting. She joined Apollo in 2020.
Wednesday, October 12, 2022 at 2:00:00 PM UTC
Goran Dautovic, Marta Ostroumoff, Rebecca Marsden
*Note: The time shown may reflect your local time zone. Check the agenda for the correct time.
Autonomous Vehicles: The Risk Challenge Ahead
Rebecca Marsden | Head of Innovation, Apollo ibott
Marta Ostroumoff | CFO, Oxbotica
Goran Dautovic | Vice President of Public Policy, Project 3 Mobility
This session will feature presenters from different perspectives of the autonomous vehicle ecosystem discussing the future of AV. During this session, you will hear about the timeline for mass AV deployment, what mass AV deployment will look like, and how it will differ between different markets, including the UK, EU and USA. Finally, they will cover the insurance challenges that lie ahead, as well as some suggested solutoins.